Ledger.Open graph →
SEC Form D · filed November 26, 2018

Advantagene, Inc

Offering
$28.7M
Sold
$28.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AUBURNDALE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Alan C. Smith · Auburndale, MADirectorStephen C. Rocamboli · Auburndale, MAExecEstuardo Aguilar-Cordova · Auburndale, MAExec · DirectorEdward J. Benz · Auburndale, MADirectorSean C. Stalfort · Auburndale, MADirectorUdi C. Merav · Auburndale, MADirectorLaura Aguilar · Auburndale, MAExecChris C. Martell · Auburndale, MADirectorPaul C. Manning · Auburndale, MADirectorAlan C. Smith · Auburndale, MADirectorStephen C. Rocamboli · VILLANOVA, PAExecChris C. Martell · Auburndale, MADirectorEstuardo Aguilar-Cordova · Auburndale, MAExec · DirectorPaul C. Manning · Auburndale, MADirectorEdward J. Benz · Auburndale, MADirectorSean C. Stalfort · Auburndale, MADirectorUdi C. Merav · Auburndale, MADirectorLaura Aguilar · Auburndale, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗